Jeff Yass’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-18,166
Closed -$1.13M 13774
2023
Q4
$1.13M Sell
18,166
-1,253
-6% -$31.1K ﹤0.01% 6699
2023
Q3
$431K Buy
+19,419
New +$408K ﹤0.01% 8577

Jeff Yass's RYZB Position: Q1 2024 in Review

Jeff Yass sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 18,166 shares — an estimated $1.13M sold.

Jeff Yass first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $1.13M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

  • Jeff Yass reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Jeff Yass sold 18,166 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $1.13M.
  • Jeff Yass first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • Jeff Yass's RayzeBio, Inc. Common Stock position peaked at $1.13M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.